SCHEMBL9921367

SCHEMBL9921367

FC(F)(F)c1cc(CNc2ncnc3ccccc23)ccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 10/20 0.63
RPS6KB1 P23443 10/20 0.63
AURKB Q96GD4 2/20 0.63
EGFR P00533 3/20 0.63
NR2F2 P24468 3/20 0.58
GALR3 O60755 2/20 0.58
RAB9A P51151 1/20 0.58
HTT P42858 2/20 0.56
TSHR P16473 2/20 0.56
LMNA P02545 1/20 0.56
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
USP1 O94782 2/20 0.56
WDR48 Q8TAF3 2/20 0.56
PDE5A O76074 1/20 0.55
POLB P06746 1/20 0.53
USP2 O75604 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13191861 0.86 EGFR (0.58) AURKARPS6KB1AURKBEGFRNR2F2
SCHEMBL13170968 0.81 EGFR (0.67) EGFRNR2F2GALR3RAB9AHTT
SCHEMBL12175974 0.81 RAD52 (0.64) LMNAUSP1WDR48PDE5AALDH1A1
SCHEMBL27848528 0.81 AURKA (0.72) AURKARPS6KB1AURKBEGFR
SCHEMBL8491665 0.81 GALR3 (0.44) AURKARPS6KB1AURKBEGFRNR2F2
SCHEMBL8497012 0.79 HTT (0.65) AURKAEGFRNR2F2GALR3RAB9A
SCHEMBL9430554 0.79 EGFR (0.69) AURKARPS6KB1EGFRNR2F2GALR3
SCHEMBL9921507 0.78 EGFR (1.00) EGFRNR2F2GALR3RAB9AHTT
SCHEMBL666618 0.78 AURKA (1.00) AURKARPS6KB1AURKB
SCHEMBL9430904 0.77 EGFR (0.68) AURKARPS6KB1AURKBEGFRNR2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 US disclosed
WO-2012079079-A1 PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-14 WO disclosed
WO-2011011522-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 AURKA 1451/4885RPS6KB1 133/4885AURKB 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.